title: Benefits exceed risks of newer antidepressant medications in youth--maybe.
authors.affiliation: Division of Neurosciences Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA. john.march@duke.edu
authors.forename: J S
authors.initials: JS
authors.lastname: March
authors.forename: B
authors.initials: B
authors.lastname: Vitiello
mesh_terms: D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D001521:Behavior Therapy; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000628:therapy; D015990:Placebo Effect; D018570:Risk Assessment; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013405:Suicide
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors